Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: Initial Results From CHRYSALIS-2 Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dose-Finding Phase 1B Study of Subcutaneous Atezolizumab in Advanced NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Results of Osimertinib Plus Platinum-Pemetrexed in Newly Diagnosed EGFR Mutation-Positive NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Managing IRRs During Amivantamab Treatment in the CHRYSALIS Study May 30, 2023
Lung Cancer Impact of Systemic Inflammation on NSCLC Patients’ Prognosis With Immunotherapy or Chemo May 29, 2023
Lung Cancer,Other Cancers A Phase 3 Study on Serplulimab Plus Chemo for First-Line ES-SCLC May 15, 2023
Lung Cancer,Other Cancers Pembrolizumab With Pemetrexed-Platinum for Metastatic Non-squamous NSCLC May 15, 2023
Lung Cancer,Other Cancers Biosimilar CT-P16 Versus Reference Bevacizumab in Metastatic NSCLC May 15, 2023
